跳至主要内容
临床试验/PACTR202201680255620
PACTR202201680255620已完成4 期

Efficacy of intraoperative low dose intravenous amiodarone in pharmacologic cardioversion in patients with preoperative atrial fibrillation presenting for mitral valve replacement surgery Randomized control trial

未提供0 个研究点目标入组 90 人开始时间: 2022年1月24日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • ·       All elective isolated cases undergoing mitral valve replacement with a preoperative atrial fibrillation rhythm > 100/min as evidenced by ECG.
  • ·       ASA physical status 2-5
  • ·       Sex (males and females)
  • ·       Age 18-70 years.

排除标准

  • ·       Patients are refusing to participate in the study.
  • ·       Below 18 or above 60 years.
  • ·       Emergency and urgent patients.
  • ·       Patients are undergoing combined valve or CABG surgery.
  • ·       Patients with previous PCI.
  • ·       Patients with rhythm defects evidenced by ECG.
  • ·       Patient on amiodarone or other rhythm modifying drugs, e.g., Digoxin, Beta Blockers, CCBs, etc.
  • ·       Patients with preoperative lung conditions or O2 saturation below 90%.
  • ·       Patients with preoperative abnormal hepatic profiles identified by double average values of ALT/AST or bilirubin or hypoalbuminemia
  • ·       Patients with preoperative renal impairment identified by serum creatinine more than 1.7 mg/dL
  • ·       Abnormal thyroid profile or any history suggestive of thyroid diseases.
  • ·       Diabetic patients, as the study, include Dextrose 5% based medication.

研究者

发起方
未提供

相似试验